文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

正常和失调的神经鞘脂代谢:对足细胞损伤的影响及其他作用。

Normal and Dysregulated Sphingolipid Metabolism: Contributions to Podocyte Injury and Beyond.

机构信息

Peggy and Harold Katz Family Drug Discovery Center, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.

出版信息

Cells. 2024 May 22;13(11):890. doi: 10.3390/cells13110890.


DOI:10.3390/cells13110890
PMID:38891023
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11171506/
Abstract

Podocyte health is vital for maintaining proper glomerular filtration in the kidney. Interdigitating foot processes from podocytes form slit diaphragms which regulate the filtration of molecules through size and charge selectivity. The abundance of lipid rafts, which are ordered membrane domains rich in cholesterol and sphingolipids, near the slit diaphragm highlights the importance of lipid metabolism in podocyte health. Emerging research shows the importance of sphingolipid metabolism to podocyte health through structural and signaling roles. Dysregulation in sphingolipid metabolism has been shown to cause podocyte injury and drive glomerular disease progression. In this review, we discuss the structure and metabolism of sphingolipids, as well as their role in proper podocyte function and how alterations in sphingolipid metabolism contributes to podocyte injury and drives glomerular disease progression.

摘要

足细胞的健康对于维持肾脏中肾小球的正常过滤功能至关重要。足细胞的指状突起形成裂孔隔膜,调节分子通过大小和电荷选择性的过滤。在裂孔隔膜附近,富含胆固醇和鞘脂的有序膜域脂质筏的丰富度突出了脂质代谢在足细胞健康中的重要性。新兴的研究表明,鞘脂代谢通过结构和信号作用对足细胞健康的重要性。鞘脂代谢失调已被证明会导致足细胞损伤,并推动肾小球疾病的进展。在这篇综述中,我们讨论了鞘脂的结构和代谢,以及它们在正常足细胞功能中的作用,以及鞘脂代谢的改变如何导致足细胞损伤并推动肾小球疾病的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f52/11171506/6ddf250cd7da/cells-13-00890-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f52/11171506/9c42d0b446f0/cells-13-00890-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f52/11171506/6ddf250cd7da/cells-13-00890-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f52/11171506/9c42d0b446f0/cells-13-00890-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f52/11171506/6ddf250cd7da/cells-13-00890-g002.jpg

相似文献

[1]
Normal and Dysregulated Sphingolipid Metabolism: Contributions to Podocyte Injury and Beyond.

Cells. 2024-5-22

[2]
Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases.

J Am Soc Nephrol. 2021-1

[3]
Targeting podocyte-associated diseases.

Adv Drug Deliv Rev. 2010-9-7

[4]
Mechanistic Insights Into Redox Damage of the Podocyte in Hypertension.

Hypertension. 2025-1

[5]
Podocyte Sphingolipid Signaling in Nephrotic Syndrome.

Cell Physiol Biochem. 2021-4-17

[6]
Podocyte pathology and nephropathy - sphingolipids in glomerular diseases.

Front Endocrinol (Lausanne). 2014-7-30

[7]
Interplay of lipid metabolism and inflammation in podocyte injury.

Metabolism. 2024-1

[8]
Out on a LIM: chronic kidney disease, podocyte phenotype and the Wilm's tumor interacting protein (WTIP).

Trans Am Clin Climatol Assoc. 2011

[9]
Role of Sphingolipid Signaling in Glomerular Diseases: Focus on DKD and FSGS.

J Cell Signal. 2020-9

[10]
Translational Aspects of Sphingolipid Metabolism in Renal Disorders.

Int J Mol Sci. 2017-11-25

引用本文的文献

[1]
The Life of a Kidney Podocyte.

Acta Physiol (Oxf). 2025-8

[2]
Exploring the non-targeted metabolomic landscape in endurance-trained runners following 10 weeks of different dietary patterns and concomitant training.

J Int Soc Sports Nutr. 2025-12

[3]
Inflammation in glomerular diseases.

Front Immunol. 2025-3-4

[4]
From Adipose to Ailing Kidneys: The Role of Lipid Metabolism in Obesity-Related Chronic Kidney Disease.

Antioxidants (Basel). 2024-12-16

[5]
Sphingolipids and Chronic Kidney Disease.

J Clin Med. 2024-8-26

本文引用的文献

[1]
Chronic kidney disease in a murine model of non-alcoholic steatohepatitis (NASH).

Kidney Int. 2024-3

[2]
Progression of albuminuria and podocyte injury in focal segmental glomerulosclerosis inhibited by enhanced glycosphingolipid GM3 via valproic acid.

Sci Rep. 2023-12-15

[3]
Circulating Sphingolipids in Insulin Resistance, Diabetes and Associated Complications.

Int J Mol Sci. 2023-9-13

[4]
Enhanced Levels of Glycosphingolipid GM3 Delay the Progression of Diabetic Nephropathy.

Int J Mol Sci. 2023-7-12

[5]
Regulation of NLRP3 Inflammasome Activation and Inflammatory Exosome Release in Podocytes by Acid Sphingomyelinase During Obesity.

Inflammation. 2023-10

[6]
Ganglioside GM1 and the Central Nervous System.

Int J Mol Sci. 2023-5-31

[7]
Identification of Glomerular and Plasma Apolipoprotein M as Novel Biomarkers in Glomerular Disease.

Kidney Int Rep. 2023-2-4

[8]
Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathy.

J Clin Invest. 2023-6-1

[9]
Loss of S1P Lyase Expression in Human Podocytes Causes a Reduction in Nephrin Expression That Involves PKCδ Activation.

Int J Mol Sci. 2023-2-7

[10]
Apolipoprotein M/sphingosine 1-phosphate protects against diabetic nephropathy.

Transl Res. 2023-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索